Earnings Highlights from Cardinal Health’s (CAH) Q4 2024 Financial Results

Wednesday, 14 August 2024, 13:23

Cardinal Health, a leading pharmaceuticals distributor, reported significant growth in its Q4 2024 earnings. Revenue surged 12% year-over-year to $59.9 billion, driven by strong performance in its Pharmaceutical and Specialty Solutions segment, which grew by 13%. The company's adjusted earnings also increased significantly, prompting a revision in EPS guidance for fiscal 2025. Overall, Cardinal Health's positive results demonstrate its robust market presence and operational efficiency.
AlphaStreet
Earnings Highlights from Cardinal Health’s (CAH) Q4 2024 Financial Results

Overview of Cardinal Health's Q4 2024 Results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, has reported impressive financial results for the fourth quarter of 2024. The company achieved a revenue increase of 12% year-over-year, reaching $59.9 billion.

Segment Performance

  • Pharmaceutical and Specialty Solutions segment revenue rose by 13% to $55.6 billion.
  • The Global Medical Products and Distribution segment grew by 2%, totaling $3.1 billion.

Financial Highlights

  1. Operating earnings exceeded expectations, more than tripling to $401 million.
  2. Net income for Q4 was $235 million, equating to $0.96 per share.
  3. Adjusted earnings per share rose 29% to $1.84.

In the full fiscal year, Cardinal Health also reported record-high operating cash flow of $3.8 billion and adjusted free cash flow of $3.9 billion.

Future Guidance

The company has raised its adjusted EPS guidance for fiscal 2025 to a range of $7.55-$7.70, up from at least $7.50, reflecting strong confidence in ongoing performance.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe